Valstead is a prescription medication that is used to treat viral infections caused by cytomegalovirus (CMV) in immunocompromised patients. Valganciclovir, the active ingredient in Valstead, is an antiviral drug that works by preventing the replication of CMV in the body.
Valstead contains valganciclovir as its active ingredient, which is a prodrug of ganciclovir. Each tablet of Valstead contains 450mg of valganciclovir.
Valstead is used to treat viral infections caused by cytomegalovirus (CMV) in immunocompromised patients, such as those undergoing organ transplantation or who have HIV/AIDS. It helps to prevent the progression of CMV infections and reduces the risk of CMV disease.
How to use Valstead:
Valstead should be taken with food, as this increases the absorption of the drug. The tablets should be swallowed whole and not crushed or chewed. It is important to take Valstead as prescribed by your doctor and not to stop taking it without their advice, even if you start feeling better.
The recommended dose of Valstead is usually based on the patient’s body weight, and can vary depending on the severity of the infection and the patient’s kidney function. Your doctor will determine the appropriate dosage for you. Do not exceed the recommended dose, and avoid taking Valstead more frequently than prescribed.
Valstead should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Mechanism of Action:
Valganciclovir, the active ingredient in Valstead, is converted into ganciclovir once it enters the body. Ganciclovir is a nucleoside analog that inhibits the replication of cytomegalovirus (CMV) by blocking the action of viral DNA polymerase.
Valstead should not be taken by pregnant or breastfeeding women, as it may harm the developing fetus or nursing infant. It may also cause serious side effects in patients with kidney disease or who are taking other medications that affect the kidneys. Patients who are allergic to valganciclovir or ganciclovir should not take Valstead.
Valstead is contraindicated in patients with severe kidney disease or a history of bone marrow suppression. It should also be avoided in patients who are allergic to valganciclovir or ganciclovir.
Valstead may interact with other medications, especially those that affect the kidneys, such as adefovir, cidofovir, and probenecid. It may also interact with drugs that affect the immune system, such as immunosuppressants and corticosteroids. Always inform your doctor of any medications you are taking before starting treatment with Valstead.
In the event of an overdose, contact your doctor or seek emergency medical attention immediately. Symptoms of overdose may include nausea, vomiting, diarrhea, and kidney damage.
Common side effects of Valstead include diarrhea, nausea, vomiting, stomach pain, headache, and fever. Serious side effects may include bone marrow suppression, kidney damage, and signs of infection. If you experience any unusual symptoms while taking Valstead, seek medical attention immediately.